Literature DB >> 31748682

CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling.

Xiang Zhang1,2, Lu Chen1,2, Wei-Qi Dang1,2, Mian-Fu Cao1,2, Jing-Fang Xiao1,2, Sheng-Qing Lv3, Wen-Jie Jiang3, Xiao-Hong Yao1,2, Hui-Min Lu1,2, Jing-Ya Miao1,2, Yan Wang1,2, Shi-Cang Yu1,2, Yi-Fang Ping1,2, Xin-Dong Liu1,2, You-Hong Cui1,2, Xia Zhang4,5, Xiu-Wu Bian6,7.   

Abstract

Tumor-associated macrophages (TAMs) constitute a large population of glioblastoma and facilitate tumor growth and invasion of tumor cells, but the underlying mechanism remains undefined. In this study, we demonstrate that chemokine (C-C motif) ligand 8 (CCL8) is highly expressed by TAMs and contributes to pseudopodia formation by GBM cells. The presence of CCL8 in the glioma microenvironment promotes progression of tumor cells. Moreover, CCL8 induces invasion and stem-like traits of GBM cells, and CCR1 and CCR5 are the main receptors that mediate CCL8-induced biological behavior. Finally, CCL8 dramatically activates ERK1/2 phosphorylation in GBM cells, and blocking TAM-secreted CCL8 by neutralized antibody significantly decreases invasion of glioma cells. Taken together, our data reveal that CCL8 is a TAM-associated factor to mediate invasion and stemness of GBM, and targeting CCL8 may provide an insight strategy for GBM treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31748682     DOI: 10.1038/s41374-019-0345-3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  56 in total

1.  ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.

Authors:  Nicole I Park; Paul Guilhamon; Kinjal Desai; Rochelle F McAdam; Ellen Langille; Madlen O'Connor; Xiaoyang Lan; Heather Whetstone; Fiona J Coutinho; Robert J Vanner; Erick Ling; Panagiotis Prinos; Lilian Lee; Hayden Selvadurai; Gurnit Atwal; Michelle Kushida; Ian D Clarke; Veronique Voisin; Michael D Cusimano; Mark Bernstein; Sunit Das; Gary Bader; Cheryl H Arrowsmith; Stephane Angers; Xi Huang; Mathieu Lupien; Peter B Dirks
Journal:  Cell Stem Cell       Date:  2017-07-14       Impact factor: 24.633

Review 2.  Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Authors:  Erwin G Van Meir; Costas G Hadjipanayis; Andrew D Norden; Hui-Kuo Shu; Patrick Y Wen; Jeffrey J Olson
Journal:  CA Cancer J Clin       Date:  2010 May-Jun       Impact factor: 508.702

3.  Glioblastoma survival in the United States before and during the temozolomide era.

Authors:  Derek R Johnson; Brian Patrick O'Neill
Journal:  J Neurooncol       Date:  2011-11-02       Impact factor: 4.130

Review 4.  Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.

Authors:  Drew A Spencer; Brenda M Auffinger; Jason P Murphy; Megan E Muroski; Jian Qiao; Yureve Gorind; Maciej S Lesniak
Journal:  Curr Cancer Drug Targets       Date:  2017       Impact factor: 3.428

Review 5.  Primary brain tumours in adults.

Authors:  Damien Ricard; Ahmed Idbaih; François Ducray; Marion Lahutte; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Lancet       Date:  2012-04-16       Impact factor: 79.321

6.  Prognostic implications of resection extent for patients with glioblastoma multiforme: a meta-analysis.

Authors:  Xue-Zhen Li; Yan-Bin Li; Yang Cao; Pei-Liang Li; Bo Liang; Ji-Dian Sun; En-Shan Feng
Journal:  J Neurosurg Sci       Date:  2016-01-29       Impact factor: 2.279

Review 7.  Microglia in brain tumors.

Authors:  Manuel B Graeber; Bernd W Scheithauer; Georg W Kreutzberg
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

Review 8.  Cancer stem cells in glioblastoma.

Authors:  Justin D Lathia; Stephen C Mack; Erin E Mulkearns-Hubert; Claudia L L Valentim; Jeremy N Rich
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

9.  Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.

Authors:  Xiaoguang Fang; Wenchao Zhou; Qiulian Wu; Zhi Huang; Yu Shi; Kailin Yang; Cong Chen; Qi Xie; Stephen C Mack; Xiuxing Wang; Angel M Carcaboso; Andrew E Sloan; Gaoliang Ouyang; Roger E McLendon; Xiu-Wu Bian; Jeremy N Rich; Shideng Bao
Journal:  J Exp Med       Date:  2016-12-06       Impact factor: 14.307

10.  Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway.

Authors:  Chengdong Ji; Lang Yang; Weijing Yi; Dongfang Xiang; Yanxia Wang; Zhihua Zhou; Feng Qian; Yong Ren; Wei Cui; Xia Zhang; Peng Zhang; Ji Ming Wang; Youhong Cui; Xiuwu Bian
Journal:  Oncogene       Date:  2018-04-17       Impact factor: 9.867

View more
  36 in total

Review 1.  Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells.

Authors:  Xiaojin Liu; Yuan Liu; Yiwei Qi; Yimin Huang; Feng Hu; Fangyong Dong; Kai Shu; Ting Lei
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis.

Authors:  Xin Shu; Xiao-Xia Chen; Xin-Dan Kang; Min Ran; You-Lin Wang; Zhen-Kai Zhao; Cheng-Xin Li
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

3.  CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity.

Authors:  Eun-Sook Kim; Su-Min Nam; Hye Kyung Song; Seungeun Lee; Kyoungmee Kim; Hyun Kyung Lim; Hyunsook Lee; Kyu-Tae Kang; Yeo-Jung Kwon; Young-Jin Chun; So Yeon Park; Joohee Jung; Aree Moon
Journal:  Oncogene       Date:  2021-04-08       Impact factor: 9.867

Review 4.  Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.

Authors:  Wenjing Xuan; Maciej S Lesniak; Charles David James; Amy B Heimberger; Peiwen Chen
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

Review 5.  Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.

Authors:  Shota Aoyama; Ryosuke Nakagawa; James J Mulé; Adam W Mailloux
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

6.  Co-culturing polarized M2 Thp-1-derived macrophages enhance stemness of lung adenocarcinoma A549 cells.

Authors:  Xiaocheng Zhang; Mingyang Zhu; Zipu Hong; Chengshui Chen
Journal:  Ann Transl Med       Date:  2021-04

7.  Construction of Molecular Subtypes and Related Prognostic and Immune Response Models Based on M2 Macrophages in Glioblastoma.

Authors:  Kai Xiao; Shushan Zhao; Jian Yuan; Yimin Pan; Ya Song; Lanhua Tang
Journal:  Int J Gen Med       Date:  2022-01-26

Review 8.  Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors.

Authors:  Deepak Upreti; David Bakhshinyan; Darin Bloemberg; Parvez Vora; Chitra Venugopal; Sheila K Singh
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 9.  CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.

Authors:  Jan Korbecki; Klaudyna Kojder; Donata Simińska; Romuald Bohatyrewicz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

Review 10.  Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.

Authors:  Jun Ma; Clark C Chen; Ming Li
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.